Texas Tech University

A draft sequence of a diploid A cotton genome released yesterday will lay the groundwork for sequencing the tetraploid genome of widely cultivated cotton species.

The test is the latest of several Alzheimer's biomarker panels developed on Rules-Based Medicine's DiscoveryMAP platform. The company plans to develop a specialized assay for research use by next year with a lab-developed test potentially following shortly thereafter.

The $200,000 grant also dovetails with an existing grant under which the University of Oklahoma Health Sciences Center and Pure Vaccine Solutions aim to look for new disease-specific biomarkers for West Nile virus. Both Receptor Logic and Pure Vaccine Solutions are portfolio companies of VC shop Emergent Technologies.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

Nature News writes that researchers are still wrangling over the role of the p-value.

In Nature this week: paternal age associated with de novo mutations in children, and more.